Embla Medical hf 관리
관리 기준 확인 3/4
Embla Medical hf CEO는 Sveinn Solvason, Apr2022 에 임명되었습니다 의 임기는 2.58 년입니다. 총 연간 보상은 $ 1.18M, 48.8% 로 구성됩니다. 48.8% 급여 및 51.2% 보너스(회사 주식 및 옵션 포함). 는 DKK 2.45M 가치에 해당하는 회사 주식의 0.016% 직접 소유합니다. 2.45M. 경영진과 이사회의 평균 재임 기간은 각각 2.6 년과 15.8 년입니다.
주요 정보
Sveinn Solvason
최고 경영자
US$1.2m
총 보상
| CEO 급여 비율 | 48.8% |
| CEO 임기 | 2.6yrs |
| CEO 소유권 | 0.02% |
| 경영진 평균 재임 기간 | 2.6yrs |
| 이사회 평균 재임 기간 | 15.8yrs |
최근 관리 업데이트
Recent updates
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 25
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)
Oct 17Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?
Oct 02Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion
Aug 22Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 26Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)
Jul 17Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$69m |
| Jun 30 2024 | n/a | n/a | US$61m |
| Mar 31 2024 | n/a | n/a | US$57m |
| Dec 31 2023 | US$1m | US$576k | US$58m |
| Sep 30 2023 | n/a | n/a | US$52m |
| Jun 30 2023 | n/a | n/a | US$45m |
| Mar 31 2023 | n/a | n/a | US$43m |
| Dec 31 2022 | US$780k | US$409k | US$43m |
보상 대 시장: Sveinn 의 총 보상 ($USD 1.18M ) Danish 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.97M ).
보상과 수익: Sveinn 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Sveinn Solvason (46 yo)
2.6yrs
테뉴어
US$1,180,000
보상
Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President & CEO | 2.6yrs | US$1.18m | 0.016% DKK 2.4m | |
| Founder | no data | US$25.00k | 데이터 없음 | |
| Chief Financial Officer | 2.2yrs | 데이터 없음 | 데이터 없음 | |
| Chief Operating Officer | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Investor Relations Director | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of People | no data | US$242.00k | 0.0083% DKK 1.2m | |
| Chief Commercial Officer | no data | US$600.00k | 0.0030% DKK 452.1k | |
| Executive Vice President of EMEA & APAC | 7yrs | 데이터 없음 | 0.023% DKK 3.5m | |
| President of Americas | no data | 데이터 없음 | 0.0031% DKK 465.7k | |
| Executive Vice President of Research & Development | 2.6yrs | 데이터 없음 | 0.00014% DKK 21.1k |
2.6yrs
평균 재임 기간
50yo
평균 연령
경험이 풍부한 관리: EMBLA 의 관리팀은 경험 ( 2.6 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman of the Board | 19.8yrs | US$108.00k | 0.048% DKK 7.2m | |
| Vice Chairman of the Board | 16.8yrs | US$72.00k | 데이터 없음 | |
| Independent Director | 11.7yrs | US$43.00k | 0.0062% DKK 928.4k | |
| Director | 15.8yrs | US$50.00k | 데이터 없음 | |
| Independent Director | 3.7yrs | US$43.00k | 데이터 없음 |
15.8yrs
평균 재임 기간
67yo
평균 연령
경험이 풍부한 이사회: EMBLA 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 15.8 년).